gefitinib has been researched along with Cancer of the Thymus in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akashi, A; Funaki, S; Kadota, Y; Nakagiri, T; Okumura, M; Shiono, H; Takeuchi, Y | 1 |
Breinig, M; Chiosis, G; Dienemann, H; Giaccone, G; Goeppert, B; Harjung, A; Hartmann, A; Kern, MA; Malz, M; Mayer, P; Neumann, O; Penzel, R; Rieker, RJ; Schirmacher, P | 1 |
2 other study(ies) available for gefitinib and Cancer of the Thymus
Article | Year |
---|---|
Does gefitinib have effects on EGFR mutation-positive thymoma? -Case report of thymoma recurrence.
Topics: Antineoplastic Agents; Combined Modality Therapy; ErbB Receptors; Fatal Outcome; Female; Gefitinib; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Quinazolines; Reoperation; Thoracic Surgery, Video-Assisted; Thymoma; Thymus Neoplasms | 2014 |
Heat shock protein 90-sheltered overexpression of insulin-like growth factor 1 receptor contributes to malignancy of thymic epithelial tumors.
Topics: Aged; Apoptosis; Benzoquinones; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Survival; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Gefitinib; HSP90 Heat-Shock Proteins; Humans; Immunohistochemistry; Infant; Infant, Newborn; Lactams, Macrocyclic; Male; Middle Aged; Neoplasms, Glandular and Epithelial; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; Receptor, IGF Type 1; RNA Interference; Signal Transduction; Thymus Neoplasms | 2011 |